In this study, MGDG showed dose-dependent cytotoxicity in pancreatic cancer cell lines, as evidenced by increased mitochondrial cytochrome c release and activation of caspase-3 followed by PARP, which resulted in apoptosis. This evidence concerns the gene CASP3 and familial pancreatic carcinoma.